Investing Profile

Diana Bernstein

InvestorVC
Principal at Northpond Ventures
northpondventures.comCambridge, Massachusetts
Photo of Diana Bernstein, Principal at Northpond Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Pennsylvania Network
330 CONNECTIONS
Flagship Pioneering Network
58 CONNECTIONS
Flagship Pioneering Network
58 CONNECTIONS
Flagship Pioneering Network
58 CONNECTIONS
University of Maryland Network
56 CONNECTIONS
cb
$100K - $5.0M
$1.5M
2
CompanyStageDateRound SizeTotal Raised
Code Biotherapeutics
Series AJun 2022$75M
$85M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Victor Stone (82VS), Dima Kuzmin (4BIO Capital)
OMass Therapeutics
Series BApr 2022$95M
$95M
Co-investors: Scott Biller (GV (Google Ventures)), Vidu Shanmugarajah (GV (Google Ventures)), Laia Crespo (Sanofi Ventures)
Associate PwC ConsultingPresent
Project Manager Leadiant Biosciences, Inc.Present
PhD Candidate Penn Medicine Co-Investment ProgramPresent
Fellow Flagship PioneeringPresent
Consultant Flagship PioneeringPresent
Associate Flagship PioneeringPresent
Senior Associate, MRL Ventures Fund MerckPresent
Vice President Northpond VenturesPresent
Board Observer Incendia TherapeuticsPresent
Board Director OMass TherapeuticsPresent
Board Director Code BiotherapeuticsPresent
Board Director Mestag TherapeuticsPresent
Board Director CAMP4 TherapeuticsPresent
Board Director Torque BioPresent
Principal Northpond VenturesPresent
Director Northpond VenturesPresent
University of Pennsylvania PhD Pharmacology
University of Maryland BS Finance, Cell Biology & Genetics